User profiles for Osaid Alser

Osaid Alser, MD, MSc(Oxon), FICS(Jr.)

Surgeon-scientist in training | TTUHSC, MGH/HMS/Oxford/QMUL/IUG Palestine (previously)
Verified email at mgh.harvard.edu
Cited by 8195

[HTML][HTML] Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

…, E Li, OM Omar, JFF Simoes, TEF Abbott, O Alser… - The Lancet, 2020 - thelancet.com
Background The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
on postoperative recovery needs to be understood to inform clinical decision making during …

[HTML][HTML] Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review

…, RE Baticulon, M Kadhum, M Alser… - BMJ global …, 2020 - gh.bmj.com
Objectives To estimate COVID-19 infections and deaths in healthcare workers (HCWs) from
a global perspective during the early phases of the pandemic. Design Systematic review. …

[HTML][HTML] Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort …

…, T Gala, I Al-Slaibi, H Tahboub, OH Alser… - The Lancet Infectious …, 2018 - thelancet.com
Background Surgical site infection (SSI) is one of the most common infections associated
with health care, but its importance as a global health priority is not fully understood. We …

Gastrointestinal complications in critically ill patients with COVID-19

…, MA Christensen, K Breen, A Gaitanidis, O Alser… - Annals of …, 2020 - journals.lww.com
Extrapulmonary disease has been observed in patients with coronavirus disease 2019 (COVID-19).
1–3 We describe here the gastrointestinal (GI) complications of patients with severe …

Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self …

…, T Duarte-Salles, MTF Abrahao, H Alghoul, O Alser… - MedRxiv, 2020 - medrxiv.org
Background Hydroxychloroquine has recently received Emergency Use Authorization by the
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. …

[HTML][HTML] Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

…, MTF Abrahao, H Alghoul, O Alser… - The Lancet …, 2020 - thelancet.com
Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …

[HTML][HTML] Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries

…, A Adisa, K Søreide, S Al Saqqa, O Alser… - The Lancet, 2021 - thelancet.com
Background 80% of individuals with cancer will require a surgical procedure, yet little comparative
data exist on early outcomes in low-income and middle-income countries (LMICs). We …

[HTML][HTML] Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international …

…, D Vervoort, S Parker, YI Benaskeur, OH Alser… - The Lancet, 2021 - thelancet.com
Background Congenital anomalies are the fifth leading cause of mortality in children younger
than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely …

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

A Prats-Uribe, AG Sena, LYH Lai, H Alghoul, O Alser… - bmj, 2021 - bmj.com
Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to
hospital with covid-19 across three continents. Design Multinational network cohort study. …

[HTML][HTML] Thirty-day outcomes of children and adolescents with COVID-19: an international experience

…, WUR Ahmed, TM Alshammari, H Alghoul, O Alser… - …, 2021 - publications.aap.org
OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …